Millennium Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,796
| Closed | -$13.9K | – | 6684 |
|
|
2024
Q2 | $13.9K | Buy |
5,796
+841
| +17% | +$2.98K | ﹤0.01% | 5575 |
|
|
2024
Q1 | $24.4K | Sell |
4,955
-5,090
| -51% | -$25.5K | ﹤0.01% | 5796 |
|
|
2023
Q4 | $42K | Sell |
10,045
-12
| -0.1% | -$91 | ﹤0.01% | 5508 |
|
|
2023
Q3 | $149K | Sell |
10,057
-7,398
| -42% | -$136K | ﹤0.01% | 5225 |
|
|
2023
Q2 | $510K | Sell |
17,455
-6,152
| -26% | -$190K | ﹤0.01% | 4526 |
|
|
2023
Q1 | $548K | Sell |
23,607
-17,747
| -43% | -$480K | ﹤0.01% | 4542 |
|
|
2022
Q4 | $595K | Buy |
41,354
+1,620
| +4% | +$31.3K | ﹤0.01% | 4608 |
|
|
2022
Q3 | $953K | Sell |
39,734
-594
| -1% | -$15.3K | ﹤0.01% | 4379 |
|
|
2022
Q2 | $804K | Buy |
40,328
+1,099
| +3% | +$24.4K | ﹤0.01% | 4574 |
|
|
2022
Q1 | $1.39M | Sell |
39,229
-1,249
| -3% | -$46.4K | ﹤0.01% | 4208 |
|
|
2021
Q4 | $1.81M | Buy |
40,478
+3,773
| +10% | +$226K | ﹤0.01% | 3869 |
|
|
2021
Q3 | $2.61M | Buy |
36,705
+2,973
| +9% | +$338K | ﹤0.01% | 3600 |
|
|
2021
Q2 | $4.45M | Buy |
33,732
+2,575
| +8% | +$322K | ﹤0.01% | 2905 |
|
|
2021
Q1 | $4.17M | Buy |
+31,157
| New | +$3.95M | ﹤0.01% | 2776 |
|
|
2020
Q3 | – | Sell |
-477
| Closed | -$37K | – | 4910 |
|
|
2020
Q2 | $37K | Buy |
+477
| New | +$32.4K | ﹤0.01% | 4069 |
|
|
2019
Q3 | – | Sell |
-288
| Closed | -$35K | – | 4641 |
|
|
2019
Q2 | $35K | Sell |
288
-87
| -23% | -$12.9K | ﹤0.01% | 3964 |
|
|
2019
Q1 | $62K | Sell |
375
-79
| -17% | -$11.8K | ﹤0.01% | 3890 |
|
|
2018
Q4 | $72K | Sell |
454
-386
| -46% | -$86.4K | ﹤0.01% | 3587 |
|
|
2018
Q3 | $258K | Sell |
840
-176
| -17% | -$55.6K | ﹤0.01% | 3546 |
|
|
2018
Q2 | $358K | Buy |
+1,016
| New | +$315K | ﹤0.01% | 3316 |
|
Other funds holding ASLN
Millennium Management's ASLN Position: Q3 2024 in Review
Millennium Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 5,796 shares — an estimated $13.9K sold.
Millennium Management first reported a position in ASLN in Q2 2018 and held it in 20 quarters. The position peaked at $4.45M in Q2 2021. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.
- Millennium Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
- Millennium Management sold 5,796 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $13.9K.
- Millennium Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2018 and held it in 20 quarters.
- Millennium Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $4.45M in Q2 2021.
- 1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.
Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.